Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-306

4 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 16729-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mg azacitidine-for-inj-carton)

Principal Display Panel (100 mg azacitidine-for-inj-carton)
Packaging label for Azacitidine for Injection 100 mg lyophilized powder by Accord Healthcare Inc. The label indicates the product must be diluted and is for subcutaneous and intravenous use only. It cautions that the drug is a cytotoxic agent and is supplied as one single-dose vial. Storage instructions for the unconstituted vial are included, as well as manufacturer details from Intas Pharmaceuticals Limited, India.*
FDA Label Image

Principal Display Panel (100 mg azacitidine-for-inj-label)

Principal Display Panel (100 mg azacitidine-for-inj-label)
Packaging label for Azacitidine 100 mg injection powder, lyophilized for solution, for subcutaneous and intravenous use. The label includes dosage form details, manufacturer Accord Healthcare Inc., storage instructions, and a caution indicating cytotoxic agent status. The label also states it is a single-dose vial with Rx only status.*
FDA Label Image

Kaplan-meier Curve Of Time To Death From Any Cause: (intent-to-treat Population) (Azacitidine For Inj Plot)

Kaplan-meier Curve Of Time To Death From Any Cause:  (intent-to-treat Population) (Azacitidine For Inj Plot)
A Kaplan-Meier survival curve chart comparing the proportion surviving over time (months from randomization) between two groups labeled AZA (Azacitidine) and CCR. The chart includes a log-rank p-value, hazard ratio with confidence interval, death counts, and a risk table showing numbers at risk for both groups over time.*
FDA Label Image

Azacitidine For Inj Structure

Azacitidine For Inj Structure
Chemical structure of azacitidine, the active ingredient in the product Azacitidine injection, powder, lyophilized, for solution by Accord Healthcare Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.